This study demonstrates that BQ323636.1 (BQ) drives lipid metabolism in ER-positive breast cancer by upregulating ACSL4 through disruption of the NCOR2-PPARγ interaction, enhancing FAO to fuel tumor growth. Here, ACSL4 is linked to neoplasm.